NINA Medical

NINA Medical Overview

NINA Medical pioneers a non-invasive treatment for Benign Prostatic Hyperplasia (BPH), a common, non-cancerous enlargement of the prostate that significantly impacts the quality of life and increases the risk of complications in aging men. NINA Medical is at the forefront of this field, offering the world's first non-invasive ultrasound-based treatment, which ensures unparalleled comfort and precision. Founded by experts in medical physics, the company's core technology enables a truly non-invasive (distinct from minimally invasive) approach to the prostate, facilitating both imaging and treatment of BPH within a urologist's office. This groundbreaking solution promotes early intervention without the need for invasive procedures, ensuring men receive treatment without the discomfort associated with traditional methods. NINA Medical has demonstrated technological readiness through animal trials and a preliminary clinical study involving 20 patients, and is now preparing for its first-in-human clinical trial. The company has consistently received support from the Israel Innovation Authority (2019, 2021, 2024) and is backed by private investors.

Cumulative Funding Raised Over Time ($)

Latest News

Jul 25, 2023 · www.calcalistech.com

growth-positive

Israeli startup develops non-invasive solution for Benign Prostatic Hyperplasia | CTech

NINA Medical has raised $1.5 million to develop a non-invasive treatment for enlarged prostate, a condition affecting over 50% of men over 50. The companys solution allows for examination and treatment of the prostate from the perineum, a completely non-invasive approach. The companys CEO, Shmuel Ben-Ezra, believes this will encourage men to seek treatment on time, avoiding medical complications and preserving their quality of life. The company plans to use the investment for system preparation for clinical trials, and for the development of a regulatory path and reimbursement strategy.

InvestmentExpand

Sep 15, 2022 · nocamels.com

growth-positive

World's First Noninvasive Prostate Treatment Developed By Israel

Israeli startup NINA Medical has developed the worlds first noninvasive treatment for enlarged prostates. The treatment, called LOTUS-1, uses high intensity focused ultrasound (HIFU) to burn selected points inside the prostate. This new option eliminates the need for invasive surgery and offers potential applications in other medical fields. NINA Medical is currently conducting a preliminary clinical trial in Israel and is crowdfunding through the Pipelbiz platform.

Customers

Funding

Team Members

7

Employees: 1-10

Web & Social Links

Locations

Netanya, Israel

Photos & Videos

1 item(s)

NINA Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info